SEC Comment Letter 0000000000-23-004606 to JAAG Enterprises Ltd. (JAGL) (CIK 0001951051)
JAAG Enterprises Ltd. (JAGL) (CIK 0001951051)
Date: May 3, 2023 · CIK: 0001951051 · Accession: 0000000000-23-004606
AI Filing Summary & Sentiment
File numbers found in text: 333-267995
Show Raw Text
United States securities and exchange commission logo
May 3, 2023
Jeffrey Chau
Chief Executive Officer
JAAG Enterprises Ltd.
1716 13 Avenue NW
Calgary, AB T2N 1L1
Canada
Re:JAAG Enterprises Ltd.
Amendment No. 2 to Registration Statement on Form S-1
Filed April 19, 2023
File No. 333-267995
Dear Jeffrey Chau:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our February 8, 2023 letter.
Amendment No. 2 to Registration Statement on Form S-1
Cover Page
1.Disclose that trading in your securities may be prohibited under the Holding Foreign
Companies Accountable Act, as amended by the Consolidated Appropriations Act, 2023,
and related regulations if the PCAOB determines that it cannot inspect or investigate
completely your auditor for a period of two consecutive years, and that as a result an
exchange may determine to delist your securities.
FirstName LastNameJeffrey Chau
Comapany NameJAAG Enterprises Ltd.
May 3, 2023 Page 2
FirstName LastName
Jeffrey Chau
JAAG Enterprises Ltd.
May 3, 2023
Page 2
Dilution, page 36
2.Please update your dilution discussion and related tables to a more recent period, such as
the latest balance sheet date presented in the filing. Your current dilution discussion and
tables are based on the net tangible book value and per share data as of June 30, 2022.
December 31, 2022 Interim Financial Statements, page F-1
3.Please revise your December 31, 2022 unaudited interim financial statements to also
include comparative statements of operations, changes in stockholders' equity, and cash
flows for the period from November 4, 2021, inception, through December 31, 2021.
Refer to Rule 8-03 of Regulation S-X for the comparative periods to be provided. Further,
your MD&A discussion of the three and six months ended December 31, 2022 should also
be expanded to discuss the comparative results for the period November 4, 2021,
inception, through December 31, 2021.
You may contact Jean Yu at 202-551-3305 or Beverly Singleton at 202-551-3328 if you
have questions regarding comments on the financial statements and related matters. Please
contact Eranga Dias at 202-551-8107 or Asia Timmons-Pierce at 202-551-3754 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing